NDRG3 and chronic myelogenous leukemia, BCR-ABL1 positive: High levels of NDRG3 were measured in patients with CML, and it was suggested that increased NDRG3 levels in K562 CML cells resulted in increased nuclear β-catenin accumulation and the subsequent upregulation of pro-oncogenic c-Myc and MDR1 (222).